CJC-1295-Modified(2mg)

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂

Molecular Weight: 3368.7

Sequence of CJC1295 (modified) without DAC:

H-Tyr-(D)Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-

Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

H-Tyr-(D)Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-

Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidopropionyl)-NH2

Real CJC-1295, there is a Lysine "linker" with along with the Maleimodoproprionic acid (DAC complex). It is difficult to produce and expensive to make. The stability of real CJC-1295 is very weak, it’s not easy to keep or ship. As a result it could be cost-prohibitive to research extensively.

CJC1295 (modified) without DAC is stable enough and easy to be researched. The bioactivity is also remarkable. This research has VALUABLE SIGNIFICANCE.

Appearance: White Freeze-dried powder

HPLC-MS Purity: 99.60%

Endotoxin Level: Less than 1.0 EU/μg of modified CJC-1295 without DAC

Freeze-dried powder can be stored at -20 degree C for over a year. Reconstituted solution should be kept in the refrigerator at 2-8 degree C and used as early as possible. Avoid multiple freeze-thaw cycles and exposure to frequent for lyophilized powder or reconstituted vials.

Modified CJC-1295 (without DAC) is a tetrasubtituted peptide of 29 amino acid length and a long acting GHRH analog, primarily functioning as a growth hormone releasing hormone (GHRH) analog.

Various experiments have been conducted to test the effectiveness of modified CJC-1295 (without DAC) in vivo and the Journal of Clinical Endocrinology & Metabolism has reported dose-dependent increases in mean plasma GH concentrations by 2-10 fold for more than 6 days and increased IGF-1 concentrations 1.5-3 fold for 9-11 days.